Amphastar Pharmaceuticals Inc

2
NAS:AMPH (USA)  
$ 43.91 +0.39 (+0.9%) 11:08 PM EST
17.02
P/B:
3.30
Volume:
449.78K
Avg Vol (2M):
477.72K
Also Trade In:
Volume:
449.78K
Avg Vol (2M):
477.72K

Business Description

Amphastar Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
ISIN : US03209R1032
Description
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Name Current Vs Industry Vs History
Cash-To-Debt 0.41
Equity-to-Asset 0.42
Debt-to-Equity 0.98
Debt-to-EBITDA 2.6
Interest Coverage 7.25
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.88
Distress
Grey
Safe
Beneish M-Score -1.77
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 50.5
9-Day RSI 40.66
14-Day RSI 37.63
6-1 Month Momentum % 15.73
12-1 Month Momentum % 44.36

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.17
Quick Ratio 1.7
Cash Ratio 1.14
Days Inventory 131.34
Days Sales Outstanding 59.82
Days Payable 29.55

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.4
Shareholder Yield % -15.29

Financials (Next Earnings Date:2024-05-09 Est.)

AMPH's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AMPH

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Amphastar Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 644.395
EPS (TTM) ($) 2.58
Beta 1.05
Volatility % 55.72
14-Day RSI 37.63
14-Day ATR ($) 1.449858
20-Day SMA ($) 44.5335
12-1 Month Momentum % 44.36
52-Week Range ($) 35.62 - 67.66
Shares Outstanding (Mil) 48.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Amphastar Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Amphastar Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Amphastar Pharmaceuticals Inc Frequently Asked Questions

What is Amphastar Pharmaceuticals Inc(AMPH)'s stock price today?
The current price of AMPH is $43.91. The 52 week high of AMPH is $67.66 and 52 week low is $35.62.
When is next earnings date of Amphastar Pharmaceuticals Inc(AMPH)?
The next earnings date of Amphastar Pharmaceuticals Inc(AMPH) is 2024-05-09 Est..
Does Amphastar Pharmaceuticals Inc(AMPH) pay dividends? If so, how much?
Amphastar Pharmaceuticals Inc(AMPH) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1